EUVIMEDEUVIMED entdecken
Open Access

IER3IP1 Mutations Cause Neonatal Diabetes Due to Impaired Proinsulin Trafficking

Hossam Montaser iD, Sonja Leppänen, Eliisa Vähäkangas, Nils Bäck, Alicia Grace, Solja Eurola, Hazem Ibrahim, Väinö Lithovius, Samuel B Stephens iD, Tom Barsby, Diego Balboa, Jonna Saarimäki-Vire und 1 weitere

Diabetes · 2025

DOI: 10.2337/db24-0119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, 2025. Verfasst von Hossam Montaser und 12 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Proinsulin, Diabetes Mellitus, Mutation, Infant, Newborn, Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Kyllikki and Uolevi Lehikoinen Foundation, Research Council of Finland, Maud Kuistilan Muistosäätiö.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immediate early response 3 interacting protein 1 (IER3IP1) is an endoplasmic reticulum (ER) resident protein, highly expressed in pancreatic cells and the developing brain cortex. Homozygous mutations in IER3IP1 have been found in individuals with microcephaly and neonatal diabetes, yet the underlying mechanism causing β-cell failure remains unclear. Here, we used differentiation of genome-edited stem cells into pancreatic islet cells to elucidate the molecular basis of IER3IP1 neonatal diabetes. Using CRISPR/Cas9 we generated two distinct IER3IP1 mutant human embryonic stem cell lines: a homozygous knock-in model of a patient mutation (IER3IP1V21G), and a knockout (KO) model (IER3IP1−/−). While these mutant stem cell lines differentiated normally into definitive endoderm and pancreatic progenitors, we observed that IER3IP1-KO stem cell-derived islets (SC-islets) presented a significant decrease in β-cell numbers and elevated ER stress. Retention using selective hooks assay revealed a threefold reduction in ER-to-Golgi trafficking of proinsulin in IER3IP1 mutant β-cells. Additionally, IER3IP1 mutant SC-islets implanted into immunocompromised mice displayed defective human insulin secretion, indicating the deleterious impact of IER3IP1 mutations on β-cell function. Our study provides valuable insights into the role of IER3IP1 in human β-cell biology and establishes a useful model to investigate ER-to-Golgi trafficking defects within β-cells. Article Highlights IER3IP1 mutations are linked to the development of microcephaly, epilepsy, and early-onset diabetes syndrome 1. However, the underlying molecular mechanisms of cell dysfunction are unknown. Using targeted genome editing, we generated specific IER3IP1 mutations in human embryonic stem cell lines that were differentiated into pancreatic islet lineages. Loss of IER3IP1 resulted in a threefold reduction in endoplasmic reticulum-to-Golgi trafficking of proinsulin in stem cell-derived β-cells, leading to β-cell dysfunction both in vitro and in vivo. Loss of IER3IP1 also triggered increased markers of endoplasmic reticulum stress, indicating the pivotal role of the endoplasmic reticulum-to-Golgi trafficking pathway for β-cell homeostasis and function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProinsulinDiabetes MellitusMutationInfant, Newborn, DiseasesHumansAnimalsInsulin-Secreting CellsMiceGolgi ApparatusEndoplasmic ReticulumEndoplasmic Reticulum StressProtein TransportHuman Embryonic Stem Cells

Substanzen

Proinsulin

Autor:innen und Institutionen

  • Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Department of Anatomy, University of Helsinki, Helsinki, Finland.
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Iowa, Iowa City, IA.
  • Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

ORCID-Profile: Hossam Montaser, Samuel B Stephens, Timo Otonkoski

Förderung

  • Kyllikki and Uolevi Lehikoinen Foundation
  • Research Council of Finland
  • Maud Kuistilan Muistosäätiö
  • Helsingin Yliopisto
  • Finska Läkaresällskapet
  • MetaStem center of excellence
  • Diabetestutkimussäätiö
  • Sigrid Juséliuksen Säätiö

Zitieren

APA

Montaser, H., Leppänen, S., Vähäkangas, E., Bäck, N., Grace, A., Eurola, S., Ibrahim, H., Lithovius, V., Stephens, S. B., Barsby, T., Balboa, D., Saarimäki-Vire, J., & Otonkoski, T. (2025). IER3IP1 Mutations Cause Neonatal Diabetes Due to Impaired Proinsulin Trafficking. Diabetes. https://doi.org/10.2337/db24-0119

Vancouver

Montaser H, Leppänen S, Vähäkangas E, Bäck N, Grace A, Eurola S, et al. IER3IP1 Mutations Cause Neonatal Diabetes Due to Impaired Proinsulin Trafficking. Diabetes. 2025. doi:10.2337/db24-0119

BibTeX
@article{Montaser2025,
  author = {Montaser, Hossam and Leppänen, Sonja and Vähäkangas, Eliisa and Bäck, Nils and Grace, Alicia and Eurola, Solja and Ibrahim, Hazem and Lithovius, Väinö and Stephens, Samuel B and Barsby, Tom and Balboa, Diego and Saarimäki-Vire, Jonna and Otonkoski, Timo},
  title = {IER3IP1 Mutations Cause Neonatal Diabetes Due to Impaired Proinsulin Trafficking},
  journal = {Diabetes},
  year = {2025},
  doi = {10.2337/db24-0119}
}
Kostenlos starten →